CPT1A and metabolic syndrome: Moreover, as a complex mixture of bioactive compounds, it has several additional benefits on energy expenditure (by phosphorylating AMPK) or lipid catabolism (by increasing CPT1a expression) in the aspects of treating dyslipidemia-related complications (Figure 6).